The National Institute on Drug Abuse (NIDA) is offering this grant to support integrated mapping and molecular profiling of brain cells mediating opioid action. This opportunity seeks innovative technologies to inventory and characterize cellular ensembles/types responding to opioids or active across opioid use stages (acute, chronic, withdrawal, relapse). Emphasis is on integrating single-cell molecular profiling with neurophysiological activity, connectivity, and spatial localization from the same cells. The goal is to generate and disseminate multimodal reference datasets to advance understanding of opioid-associated states.
Opportunity ID: 343628
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-23-035 |
Funding Opportunity Title: | Large Scale Integrated Mapping and Molecular Profiling of Cell Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 – Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Sep 19, 2022 |
Last Updated Date: | Sep 19, 2022 |
Original Closing Date for Applications: | Feb 02, 2023 |
Current Closing Date for Applications: | Feb 02, 2023 |
Archive Date: | Mar 10, 2023 |
Estimated Total Program Funding: | – |
Award Ceiling: | $700,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education For profit organizations other than small businesses Special district governments Public housing authorities/Indian housing authorities State governments Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This funding opportunity announcement (FOA) aims to support complementary research programs that adopt innovative scalable technologies to inventory, register and profile cellular ensembles and/or cell-types that produce and/or respond to opioids in the brain, or that are engaged during different stages of opioid use (acute, chronic, withdrawal, abstinence, relapse). Emphasis is on approaches capable of integrating data generated through molecular profiling of brain tissues at single-cell resolution with other data modalities , such as neurophysiological activity, connectivity and/or spatial localization, collected from the same cells. The overarching goal of the FOA is to generate and disseminate multimodal reference datasets that will be useful to the research community and will provide a foundational biological framework to advance the understanding of opioid-associated states. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-035.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00276893 | Jan 02, 2023 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277854 | Jan 02, 2023 | Feb 02, 2023 | View |
Package 1
Mandatory forms
343628 RR_SF424_5_0-5.0.pdf
343628 PHS398_CoverPageSupplement_5_0-5.0.pdf
343628 RR_OtherProjectInfo_1_4-1.4.pdf
343628 PerformanceSite_4_0-4.0.pdf
343628 RR_KeyPersonExpanded_4_0-4.0.pdf
343628 PHS398_ResearchPlan_4_0-4.0.pdf
343628 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343628 RR_Budget_3_0-3.0.pdf
343628 RR_SubawardBudget30_3_0-3.0.pdf
343628 PHS398_ModularBudget_1_2-1.2.pdf
343628 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
343628 RR_SF424_5_0-5.0.pdf
343628 PHS398_CoverPageSupplement_5_0-5.0.pdf
343628 RR_OtherProjectInfo_1_4-1.4.pdf
343628 PerformanceSite_4_0-4.0.pdf
343628 RR_KeyPersonExpanded_4_0-4.0.pdf
343628 PHS398_ResearchPlan_5_0-5.0.pdf
343628 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
343628 RR_Budget_3_0-3.0.pdf
343628 RR_SubawardBudget30_3_0-3.0.pdf
343628 PHS398_ModularBudget_1_2-1.2.pdf
343628 PHS_AssignmentRequestForm_3_0-3.0.pdf